Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

Richard B. Lipton, M. E. Bigal, K. B. Kolodner, P. B. Gorelick, K. Wilks, M. Schoebelock, G. Davidai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

Original languageEnglish (US)
Pages (from-to)1099-1101
Number of pages3
JournalNeurology
Volume63
Issue number6
StatePublished - Sep 29 2004

Fingerprint

Dipyridamole
Acetaminophen
Aspirin
Headache
Placebos
Therapeutics
Incidence

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lipton, R. B., Bigal, M. E., Kolodner, K. B., Gorelick, P. B., Wilks, K., Schoebelock, M., & Davidai, G. (2004). Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology, 63(6), 1099-1101.

Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. / Lipton, Richard B.; Bigal, M. E.; Kolodner, K. B.; Gorelick, P. B.; Wilks, K.; Schoebelock, M.; Davidai, G.

In: Neurology, Vol. 63, No. 6, 29.09.2004, p. 1099-1101.

Research output: Contribution to journalArticle

Lipton, RB, Bigal, ME, Kolodner, KB, Gorelick, PB, Wilks, K, Schoebelock, M & Davidai, G 2004, 'Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination', Neurology, vol. 63, no. 6, pp. 1099-1101.
Lipton RB, Bigal ME, Kolodner KB, Gorelick PB, Wilks K, Schoebelock M et al. Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology. 2004 Sep 29;63(6):1099-1101.
Lipton, Richard B. ; Bigal, M. E. ; Kolodner, K. B. ; Gorelick, P. B. ; Wilks, K. ; Schoebelock, M. ; Davidai, G. / Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. In: Neurology. 2004 ; Vol. 63, No. 6. pp. 1099-1101.
@article{683bfa10c49b4b2381ce212b11595d23,
title = "Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination",
abstract = "The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7{\%} of the participants developed headaches. The headaches were self-limited (69.4{\%} placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.",
author = "Lipton, {Richard B.} and Bigal, {M. E.} and Kolodner, {K. B.} and Gorelick, {P. B.} and K. Wilks and M. Schoebelock and G. Davidai",
year = "2004",
month = "9",
day = "29",
language = "English (US)",
volume = "63",
pages = "1099--1101",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

AU - Lipton, Richard B.

AU - Bigal, M. E.

AU - Kolodner, K. B.

AU - Gorelick, P. B.

AU - Wilks, K.

AU - Schoebelock, M.

AU - Davidai, G.

PY - 2004/9/29

Y1 - 2004/9/29

N2 - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

AB - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

UR - http://www.scopus.com/inward/record.url?scp=4644266898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644266898&partnerID=8YFLogxK

M3 - Article

C2 - 15452309

AN - SCOPUS:4644266898

VL - 63

SP - 1099

EP - 1101

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -